Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

AIMS/HYPOTHESIS: The EFFECT-II study aimed to investigate the effects of dapagliflozin and omega-3 (n-3) carboxylic acids (OM-3CA), individually or combined, on liver fat content in individuals with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). METHODS: This randomised placebo-contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Jan W., Lundkvist, Per, Jansson, Per-Anders, Johansson, Lars, Kvarnström, Mats, Moris, Linda, Miliotis, Tasso, Forsberg, Gun-Britt, Risérus, Ulf, Lind, Lars, Oscarsson, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096619/
https://www.ncbi.nlm.nih.gov/pubmed/29971527
http://dx.doi.org/10.1007/s00125-018-4675-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096619/
https://www.ncbi.nlm.nih.gov/pubmed/29971527
http://dx.doi.org/10.1007/s00125-018-4675-2

Ejemplares similares